Yung-Hsin Huang

Yung-Hsin Huang

Auto-generated profile, based on publicly available information

Yung-Hsin Huang

Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, 77030, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Cancer Cell
Verified
Journal Article
Closed access
LBLorenzo Brunetti
Lorenzo Brunetti
MGMichael C. Gundry
Michael C. Gundry
DSDaniele Sorcini
Daniele Sorcini
AGAnna G. Guzman
Anna G. Guzman
YHYung-Hsin Huang
Yung-Hsin Huang
MGMargaret A. Goodell
Margaret A. Goodell

18 July 2016 in Nature Genetics
Verified
Journal Article
Open access
PDF file
XZXiaotian Zhang
Xiaotian Zhang
JSJianzhong Su
Jianzhong Su
MJMira Jeong
Mira Jeong
MKMyunggon Ko
Myunggon Ko
YHYun Huang
Yun Huang
MGMargaret A Goodell
Margaret A Goodell
Margaret Goodell, Wei Li and colleagues use double-knockout mice for Dnmt3a and Tet2 to model leukemia development. Through epigenetic and transcriptional analyses, they show that loss of DNMT3A and TET2 upregulates lineage-specific transcription factors such as KLF1 in hematopoietic stem cells and accelerates malignancy. Mutations in the epigenetic modifiers DNMT3A and TET2 non-randomly co-occur in lymphoma and leukemia despite their epistasis in the methylation–hydroxymethylation pathway. Using Dnmt3a and Tet2 double-knockout mice in which the development of malignancy is accelerated, we show that the double-knockout methylome reflects regions of independent, competitive and cooperative activity. Expression of lineage-specific transcription factors, including the erythroid regulators Klf1 and Epor, is upregulated in double-knockout hematopoietic stem cells (HSCs). DNMT3A and TET2 both repress Klf1, suggesting a model of cooperative inhibition by epigenetic modifiers. These data demonstrate a dual role for TET2 in promoting and inhibiting HSC differentiation, the loss of which, along with DNMT3A, obstructs differentiation, leading to transformation.

11 July 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
YLYong Lei
Yong Lei
XZXiaotian Zhang
Xiaotian Zhang
JSJianzhong Su
Jianzhong Su
MJMira Jeong
Mira Jeong
MGMichael C. Gundry
Michael C. Gundry
MGMargaret A. Goodell
Margaret A. Goodell
Comprehensive studies have shown that DNA methylation plays vital roles in both loss of pluripotency and governance of the transcriptome during embryogenesis and subsequent developmental processes. Aberrant DNA methylation patterns have been widely observed in tumorigenesis, ageing and neurodegenerative diseases, highlighting the importance of a systematic understanding of DNA methylation and the dynamic changes of methylomes during disease onset and progression. Here we describe a facile and convenient approach for efficient targeted DNA methylation by fusing inactive Cas9 (dCas9) with an engineered prokaryotic DNA methyltransferase MQ1. Our study presents a rapid and efficient strategy to achieve locus-specific cytosine modifications in the genome without obvious impact on global methylation in 24 h. Finally, we demonstrate our tool can induce targeted CpG methylation in mice by zygote microinjection, thereby demonstrating its potential utility in early development.

18 September 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
YHYung-Hsin Huang
Yung-Hsin Huang
JSJianzhong Su
Jianzhong Su
YLYong Lei
Yong Lei
LBLorenzo Brunetti
Lorenzo Brunetti
MGMichael C. Gundry
Michael C. Gundry
MGMargaret A. Goodell
Margaret A. Goodell
DNA methylation has widespread effects on gene expression during development. However, our ability to assign specific function to regions of DNA methylation is limited by the poor correlation between global patterns of DNA methylation and gene expression. Here, we utilize nuclease-deactivated Cas9 protein fused to repetitive peptide epitopes (SunTag) recruiting multiple copies of antibody-fused de novo DNA methyltransferase 3A (DNMT3A) (dCas9-SunTag-DNMT3A) to amplify the local DNMT3A concentration to methylate genomic sites of interest. We demonstrate that dCas9-SunTag-DNMT3A dramatically increases CpG methylation at the HOXA5 locus in human embryonic kidney (HEK293T) cells. Furthermore, using a single guide RNA, dCas9-SunTag-DNMT3A is able to methylate a 4.5-kb genomic region and repress HOXA5 gene expression. Reduced representation bisulfite sequencing and RNA-seq show that dCas9-SunTag-DNMT3A methylates regions of interest with minimal impact on the global DNA methylome and transcriptome. This effective and precise tool enables site-specific manipulation of DNA methylation and may be used to address the relationship between DNA methylation and gene expression.

10 August 2018 in Genome Biology
Verified
Journal Article
Open access
PDF file
JSJianzhong Su
Jianzhong Su
YHYung-Hsin Huang
Yung-Hsin Huang
XCXiaodong Cui
Xiaodong Cui
XWXinyu Wang
Xinyu Wang
XZXiaotian Zhang
Xiaotian Zhang
WLWei Li
Wei Li
Cancers have long been recognized to be not only genetically but also epigenetically distinct from their tissues of origin. Although genetic alterations underlying oncogene upregulation have been well studied, to what extent epigenetic mechanisms, such as DNA methylation, can also induce oncogene expression remains unknown. Here, through pan-cancer analysis of 4174 genome-wide profiles, including whole-genome bisulfite sequencing data from 30 normal tissues and 35 solid tumors, we discover a strong correlation between gene-body hypermethylation of DNA methylation canyons, defined as broad under-methylated regions, and overexpression of approximately 43% of homeobox genes, many of which are also oncogenes. To gain insights into the cause-and-effect relationship, we use a newly developed dCas9-SunTag-DNMT3A system to methylate genomic sites of interest. The locus-specific hypermethylation of gene-body canyon, but not promoter, of homeobox oncogene DLX1, can directly increase its gene expression. Our pan-cancer analysis followed by functional validation reveals DNA hypermethylation as a novel epigenetic mechanism for homeobox oncogene upregulation.

1 May 2020 in Molecular Cell
Verified
Journal Article
Closed access
XZXiaotian Zhang
Xiaotian Zhang
MJMira Jeong
Mira Jeong
XHXingfan Huang
Xingfan Huang
XWXue Qing Wang
Xue Qing Wang
XWXinyu Wang
Xinyu Wang
MGMargaret A. Goodell
Margaret A. Goodell